Skip to main content
. Author manuscript; available in PMC: 2016 Aug 25.
Published in final edited form as: ACS Nano. 2015 Jul 28;9(8):8012–8021. doi: 10.1021/acsnano.5b01552

Figure 1.

Figure 1

Illustration of (a) the dual-ligand nanoparticle, and (b) targeting of the nanoparticles to metastatic sites using vascular targeting and a dual-ligand strategy. Inset: Interactions of circulating tumor cells and vascular bed.